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The highly polymorphic fourth component of human complement (C4) is usually encoded by two genes, 
C4A and C4B, adjacent o the 21-hydroxylase (21-OH) genes, 21-OHA and 21-OHB, and is also remarkable 
in the high frequency of the ‘null’ alleles, C4A*QO and C4B*QO. The molecular basis for the C4A*QO allele 
was studied in 26 families through restriction fragment length polymorphism (RFLP) analysis with C4 and 
21-OH cDNA probes after digestion of the DNA with the endonuclease HindIII. The individuals expressing 
the extended haplotype HLA-Al (of A2) Cw7 B8 C2C BfS C4AQOBl DR3 have a large deletion taking 
off the C4A and 2 1 -0HA genes. 
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1. INTRODUCTION 
The class III genes of the major histocom- 
patibility complex (MHC) code for three comple- 
ment proteins, C2, C4, and factor B (Bf), and the 
steroid 21-hydroxylase (Zl-OH) enzymes. C4 and 
21-OH are coded by two separate but closely link- 
ed loci, C4A, C4B, and 21-OHA, 21-OHB. The 
map of this region on the short arm of the sixth 
human chromosome has been established: the 
21-OH genes lie 3’ of both the C4A and C4B 
genes, and the C2 and Bf genes lie 5’ to these genes 
111. 
The fourth component of human complement 
(C4) is characterized by its extensive genetic 
polymorphism at both loci and the high frequency 
of the ‘null’ alleles, C4A*QO and C4B*QO [2-41. 
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Restriction fragment length polymorphism 
(RFLP) analysis may be useful to understand the 
molecular basis of these null alleles. Therefore, we 
have applied the technique of Southern blot 
analysis [5] using a full-length C4 cDNA and a 
21-OH probe to examine the genomic DNA of in- 
dividuals carrying a C4A*QO allele. We report here 
that the C4A*QO allele appearing in the extended 
HLA-Al Cw7 B8 C2C BR C4AQOBl DR3 
haplotype is due to a deletion of about 30 kb, in- 
cluding the C4A and 21-OHA genes. 
2. MATERIALS AND METHODS 
2.1. Family material 
The 26 families included in this study were 
selected from the material of normal families in- 
vestigated within the ‘HLA-Provinces Francaises’ 
project [6] and the Ninth International Histocom- 
patibility Workshop [7]. The members of these 
families have been typed for HLA-A, B, C, DR, 
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Bf, and C2 according to recommended methods hybridized with nick-translated heat-denatured 
WI. DNA probes for 48 h at 42°C. 
2.2. C4 typing 2.4. Probes 
The C4 variants were revealed through high- 
voltage agarose electrophoresis with subsequent 
immunofixation and hemolytic overlay [2,4,9]. 
Heterozygosity for C4A*QO was determined by 
comparing the intensities of stained C4A and C4B 
bands in all the family members. 
The C4 cDNA probe is clone A, an almost full- 
length C4B gene, 4.8 kb long [3]. The 21-OH 
probe is pC21/3c, a cDNA probe of approx. 2 kb 
which codes for all but a few hundred nucleotides 
at the 5’-end of the human 21-OH gene [ll]. 
2.3. Preparation of genomic DNA and Southern 
blot analysis 
High-M, genomic DNA was prepared from 
peripheral blood collected on K3-EDTA using stan- 
dard phenol/chloroform/isoamyl alcohol extrac- 
tion [lo]. lo-12 pg DNA samples were digested in 
a final volume of 300~1 with 30 U restriction en- 
donuclease Hind111 according to manufacturer’s 
instructions (Appligene, Strasbourg). The digested 
DNA were analysed by electrophoresis in 0.6% 
agarose gels, transferred onto nitrocellulose, 
prehybridized in 40% formamide solution and 
3. RESULTS 
26 families selected for the 
C4A*QO allele were studied. 
segregation of a 
Among the in- 
Table 1 
Extended HLA haplotypes (HLA-A, C, B, C2, Bf, C4A, 
C4B, DR) with a C4A null (C4A*QO) allele examined by 
Southern blot with the C4 and 21-OH probes 
Extended haplotypes with deleted C4A + 21-OHA genes 
Al cw7 B8 
A2 cw7 B8 
Al cw7 B8 
Al cw7 B8 
Al cw7 B8 
A2 cw7 B8 
Aw32 Cw7 B8 
Al cw7 B8 
Al cw7 B8 
A2 cw7 B8 
Al cw7 B8 
Al cw7 B8 
Al cw7 B8 
Al cw7 B8 
n.d. BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
n.d. BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR7 
n.d. BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
C2C BfS C4AQO Bl DR3 
n.d. BfS C4AQO Bl DR3 
n.d. BfS C4AQO Bl DR3 
n.d. BfS C4AQO Bl DR3 
Fig.1. Patterns A, B and C observed after Hind111 
digestion and hybridization with the C4 PAT-A probe. 
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Extended haplotypes with non-deleted C4A + 21-OH 
genes 
Aw30 Cw6 B14 C2C BfS C4AQO Bl DR7 
A2 Cw3 Bw60 C2C BfS C4AQO B2 DRw6 
Aw30 Cw3 Bw60 C2C BfS C4AQO B2 DR3 
A2 n.i. B14 C2C BfS C4AQO Bl DR7 
A3 Cw7 B7 C2C BfS C4AQO Bl DR2 
A3 Cw3 Bw62 C2C BfS C4AQO Bl DR5 
Aw30 Cw6 B13 C2C BfS C4AQO Bl DR7 
A2 Cw5 Bw44 C2C BfS C4AQO Bl DR4 
A29 Cwl Bw22 C2C BfS C4AQO Bl DR5 
A~33 Cw7 Bw44 C2C BfS C4AQO B2 n.i. 
Aw30 Cw3 Bw60 C2C BfS C4AQO B2 DR4 
A3 Cw4 B17 C2C BfF C4AQO Bl DRw6 
n.d., not done; n.i., not informative 
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dividuals having a C4A*QO allele, 52 were 
heterozygous and 3 were homozygous. After Hin- 
dII1 digestion and Southern blot analysis using the 
C4 cDNA probe, three different patterns were 
identified: 
Pattern A was composed of two bands of 31 and 
8.5 kb, respectively. 
Pattern B associated one band of 31 kb, 
sometimes duplicated with an additional band of 
25 kb, and a band of 15 kb. 
Pattern C corresponded to a heterozygous tate 
with three fragments of 31 kb (also sometimes 
duplicated), 15 and 8.5 kb (fig.1). 
The correlation between the patterns and the ex- 
tended haplotypes showed that the pattern A was 
characteristic of the three individuals homozygous 
for the C4A*QO allele and also for the HLA-Al 
Cw7 B8 C2C BfS C4AQOBl DR3 haplotype. 
Pattern C was observed in eight families where 
the HLA-Al Cw7 B8 BfS C4AQOBl DR3 
haplotype was segregating. It was also correlated 
with the HLA-A2 Cw7 B8 BfS CZC C4AQOBI 
DR3 haplotype in three families. In one family, the 
extended haplotype associated with the pattern C 
was Aw32 Cw7 B8 C2C BfS C4AQOBl DR7. 
Pattern B was observed in the family members 
not bearing a C4A*QO allele and who could be 
considered as controls. It was also present in the 
individuals carrying a C4A*QO allele occurring 
within various extended haplotypes as shown in 
table 1. 
RFLP analysis with the 21-OH probe was done 
on Hind111 digests of the DNA extracted from in- 
dividuals showing pattern A or C with the C4 
cDNA probe. The pattern obtained showed only 
the fragment of 31 kb duplicated with a second 
band of 25 kb. The 8.5 kb fragment was not 
recognized with this probe. The 15 kb fragment 
corresponding to the 5’-end of the C4 gene was 
also not recognized. 
4. DISCUSSION 
Pattern B is common to people expressing four 
C4 genes and is also observed in some individuals 
having a C4A*QO allele. This pattern results from 
the presence of Hind111 restriction sites inside and 
outside the C4 genes (fig.2). All the restriction 
fragments are recognized with the full-length C4 
cDNA probe. 
Pattern A shows a 8.5 kb fragment which cor- 
responds to a deletion taking away the restriction 
site for Hind111 normally present in the C4A gene. 
This deletion of approx. 30 kb also includes the 
21-OHA gene as the 8.5 kb fragment is not 
recognized by the 21-OH probe [1,12]. 
Pattern C corresponds to the heterozygous tate 
with one haplotype HLA-Al Cw7 C2C B8 BfS 
C4AQOBl DR3 carrying the deletion and a normal 
haplotype with two expressed C4 genes. 
A polymorphism of the C4B gene size is also 
detected on the same blots. It is responsible for the 
HIND III 
FRAGMENTS KB t 15.0 II 25.0 II 31.0 
-I 
5’ 
1 C4B SHORT )-/218onj--. 
3’ 
I 15.0 II 31.0 1 
---I 
C4A l-/PI 1 C4B LONG l_j21gOHI_ 
5’ 3’ 5’ 3’ 
I C48 SHORT C4AQO Bl HAPLOTYPE WITH DELETION OF C4A AND Zl-UHA IN THE HLA HAPLOTYPE 
5’ 3’ 
(Al) Cw7 68 CZC 6Fs C4AQO Bl DR3 
Fig.2. Molecular map of Hind111 restriction sites in different C4 haplotypes. 
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duplication of the large fragment (31 kb) 
sometimes evident. The 3 ‘-end of the C4B gene is 
located in a 31 kb fragment. The fragment con- 
taining the 3 ‘-end of a C4A and the 5 ‘-end of a 
C4B may have two possible sizes: 25 kb for a short 
C4B gene, 31 kb for a long C4B gene (fig.%). It was 
previously shown that the size difference in the 
C4B gene is due to an insertion of about 6 kb near 
the 5’-end [13]. 
The screening of a large number of haplotypes 
with a C4A null allele shows clearly that the 
molecular basis for this null allele can be different. 
In this large series, the deleted C4A and 21-OHA 
genes were only found in the extended HLA-Cw7 
B8 DR3 C2C BfS C4AQO Bl DR3 haplotype. This 
haplotype is common in patients with auto- 
immune diseases but may be found, as in our 
study, in healthy individuals although it has been 
shown that these individuals have differences in 
their immune responses predisposing to the 
development of autoimmune disorders [ 141. 
Whether the deletion of the C4A and 21-OHA 
genes plays a role in the occurrence of immune 
response abnormalities remains however to be 
demonstrated. 
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